PIM3 is constitutively expressed in pancreatic cancer, where it not only inhibits cell apoptosis by phosphorylating Bad [79] but also promotes pancreatic tumor neoangiogenesis [80]. Here, PIM3 is linked to familial pancreatic carcinoma.